Faculty Collaboration Database

Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios. Infect Control Hosp Epidemiol 2018 Dec;39(12):1484-1486

Date

10/24/2018

Pubmed ID

30348236

DOI

10.1017/ice.2018.241

Scopus ID

2-s2.0-85055537816 (requires institutional sign-in at Scopus site)   1 Citation

Abstract

In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.

Author List

Figueroa Castro CE, Palen L, Johnson C, Graham MB, Letzer D, Ledeboer N, Buchan B, Block T, Seliger H, Singh S, Behrens E, Huerta S, Munoz-Price LS

Authors

Blake W. Buchan PhD Professor in the Pathology department at Medical College of Wisconsin
Carlos E. Figueroa Castro MD Associate Professor in the Medicine department at Medical College of Wisconsin
Mary Beth Graham MD Associate Chief, Professor in the Medicine department at Medical College of Wisconsin
Nathan A. Ledeboer PhD Vice Chair, Professor in the Pathology department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Algorithms
Clostridium Infections
Cross Infection
Hospitals
Humans
Immunoenzyme Techniques
Nucleic Acid Amplification Techniques
Risk Adjustment
Wisconsin